![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CRUCELL ANNOUNCES PER.C6 COMMERCIAL LICENSING AGREEMENT WITH ADIMMUNE CORPORATION
CRUCELL ANNOUNCES PER.C6 COMMERCIAL LICENSING AGREEMENT WITH ADIMMUNE CORPORATION
Dutch biotechnology company Crucell N.V. announced that it has signed a non-exclusive PER.C6 commercial license agreement with the Taiwan-based vaccine company ADImmune Corporation.
BioSpace (http://www.marketwire.com/mw/release_html_pressroom?id=F65B254181F3F030&release_id=171434)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct